THAR
Hillstream BioPharma Inc

3,035
Mkt Cap
$163.65M
Volume
555,548.00
52W High
$9.08
52W Low
$0.952
PE Ratio
-1.06
THAR Fundamentals
Price
$4.01
Prev Close
$4.14
Open
$4.00
50D MA
$3.04
Beta
0.84
Avg. Volume
1.06M
EPS (Annual)
-$9.41
P/B
4.85
Rev/Employee
$0.00
$0.9279
Loading...
Loading...
News
all
press releases
Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer
Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela...
PR Newswire·3d ago
News Placeholder
More News
News Placeholder
Tharimmune Shareholders Approve Directors, Warrant-Linked Share Issuances and 7M Share Plan Boost
Tharimmune (NASDAQ:THAR) shareholders approved all items presented at the company's special meeting, including the election of two directors, multiple share-issuance proposals tied to warrants and a...
MarketBeat·9d ago
News Placeholder
Tharimmune Announces Expanded Role as Super Validator on Canton Network
Tharimmune Announces Expanded Role as Super Validator on Canton Network Tharimmune Announces Expanded Role as Super Validator on Canton Network PR Newswire NEW YORK, Jan. 26, 2026 Advances Digital...
PR Newswire·14d ago
News Placeholder
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering PR Newswire NEW...
PR Newswire·18d ago
News Placeholder
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering PR Newswire NEW YORK, Jan. 20...
PR Newswire·20d ago
News Placeholder
Tharimmune (NASDAQ:THAR) Stock Price Down 5.9% - What's Next?
Tharimmune (NASDAQ:THAR) Stock Price Down 5.9% - Here's Why...
MarketBeat·2mo ago
News Placeholder
Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy
Tharimmune, Inc. (NASDAQ: THAR) (Tharimmune or the Company), the first publicly traded company to leverage Canton Coin (CC) to support the Canton Networks ability to digitize traditional financial...
Business Wire·2mo ago
News Placeholder
Tharimmune (NASDAQ:THAR) Shares Up 8.9% - What's Next?
Tharimmune (NASDAQ:THAR) Trading Up 8.9% - Here's Why...
MarketBeat·3mo ago
News Placeholder
Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids
Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids Tharimmune Receives Positive FDA Feedback for TH104...
PR Newswire·3mo ago
News Placeholder
Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy
Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy PR...
PR Newswire·3mo ago
<
1
2
...
>

Latest THAR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.